Skip to main content

Table 10 Comparison of clinical characteristics between patients who died vs. those who were alive

From: Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients

 

Alive

Death

Test value

p-value

Sig.

No. = 24

No. = 9

Fever

7 (29.2%)

7 (77.8%)

6.332*

0.012

S

Facial numbness

15 (62.5%)

5 (55.6%)

0.132*

0.716

NS

Facial swelling

13 (54.2%)

6 (66.7%)

0.419*

0.518

NS

Headache

16 (66.7%)

7 (77.8%)

0.383*

0.536

NS

Facial pain

16 (66.7%)

7 (77.8%)

0.383*

0.536

NS

Rhinorrhea, blood stained

7 (29.2%)

4 (44.4%)

0.688*

0.407

NS

Orbital swelling

15 (62.5%)

8 (88.9%)

2.158*

0.142

NS

Ophthalmoplegia

10 (41.7%)

8 (88.9%)

5.887*

0.015

S

Visual loss

9 (37.5%)

7 (77.8%)

4.251*

0.039

S

Disturbed conscious

4 (16.7%)

4 (44.4%)

2.750*

0.097

NS

Motor or sensory weakness (stroke)

4 (16.7%)

2 (22.2%)

0.136*

0.712

NS

First presentation

 Eye swelling

5 (62.5%)

0 (0.0%)

2.250*

0.325

NS

 Disturbed conscious

2 (25.0%)

1 (100.0%)

 Facial swelling

1 (12.5%)

0 (0.0%)

Intranasal necrosis

21 (87.5%)

8 (88.9%)

0.012*

0.913

NS

Palatal necrosis

13 (54.2%)

6 (66.7%)

0.419*

0.518

NS

Proptosis

8 (33.3%)

5 (55.6%)

1.354*

0.245

NS

Cavernous sinus thrombosis

11 (45.8%)

7 (77.8%)

2.694*

0.101

NS

Facial skin necrosis

0 (0.0%)

2 (22.2%)

5.677*

0.017

S

Cranial nerves involvement

 Negative

18 (75.0%)

9 (100.0%)

2.750*

0.097

NS

 Facial

6 (25.0%)

0 (0.0%)